Clinical Trials Logo

Major Depressive Episode clinical trials

View clinical trials related to Major Depressive Episode.

Filter by:

NCT ID: NCT05182827 Recruiting - Clinical trials for Major Depressive Episode

Affective Touch, Hedonia and Suicidal Behavior

TOUCH-S
Start date: February 11, 2022
Phase: N/A
Study type: Interventional

Several elements suggest that suicidal vulnerability may be associated with an alteration in the perception of affective touch. On the one hand, anhedonia, characterized by a decrease in the pleasure felt, is strongly associated with suicidal ideation, independently of depression. However, the ability to feel pleasure is essential in the perception of affective touch. On the other hand, suicidal behaviors are associated with interpersonal difficulties, of which communication is an integral part, and communication is partly through touch. The investigators therefore wish to explore the perception of affective touch in suicidal behavior by using an affective tactile stimulation in 72 subjects with and without a history of suicide attempts (SA).

NCT ID: NCT05063604 Terminated - Breast Cancer Clinical Trials

Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression

CAMAD
Start date: May 10, 2022
Phase: Phase 2
Study type: Interventional

To provide evidence on the antidepressant efficacy of two therapeutic treatments: pharmacological treatment (citalopram) and psychotherapy treatment, in women diagnosed with breast cancer and major depression.

NCT ID: NCT05028738 Recruiting - Clinical trials for Major Depressive Disorder

Patient-oriented Randomized Pragmatic Feasibility Trial With rTMS in Depression and Anxiety

PORT
Start date: October 11, 2021
Phase: N/A
Study type: Interventional

This trial compares intermittent theta-burst stimulation (iTBS) to low frequency repetitive transcranial magnetic stimulation (LFR) in regards to depression and anxiety outcomes in 100 patients with treatment resistant depression (TRD).

NCT ID: NCT04999553 Recruiting - Depression Clinical Trials

Left vs. Right Non-Inferiority Trial

LeRNIT
Start date: November 8, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to test the hypothesis that low-frequency rTMS (LFR) works as well as the established intermittent thetaburst rTMS (iTBS) treatment for treatment resistant depression (TRD).

NCT ID: NCT04939649 Recruiting - Bipolar Depression Clinical Trials

Ketamine as an Adjunctive Therapy for Major Depression (2)

KARMA-Dep2
Start date: September 13, 2021
Phase: Phase 3
Study type: Interventional

Pragmatic, randomised, controlled, parallel-group, superiority trial of ketamine vs. midazolam as an adjunctive therapy for depression. The main purpose of the trial is to assess the mood-rating score difference between ketamine and midazolam from before the first infusion to 24 hours after the final infusion, supplemented by a 95% confidence interval. There will also be a 24-week follow-up after the final infusion session.

NCT ID: NCT04899609 Recruiting - Clinical trials for Major Depressive Episode

The Effects of Anger and Joy Expressions on Approach and Avoidance Behaviors in Healthy Volunteers

Start date: June 1, 2021
Phase:
Study type: Observational

Social interactions are part of our daily lives. Communicating with others is a recurring choice which is based on emotional cues, such as facial expression. Our action must be adapted to the emotional state of our interlocutor, otherwise the investigators will have poor quality interactions An emotional stimulus would cause a conditioned response (innate reaction). Thus, the presence of an angry person would automatically trigger flight behavior. More recently, however, it has been envisioned that this same avoidance behavior could be the result of a goal-directed behvior. In this case, the avoidance behavior would be the result of an evaluation of the consequences of the selected action. These goal-directed behaviors are guided by a mental representation of consequences The project aims to study behavioral choices (approach and avoidance) in response to negative and positive social cues (anger and joy) in 40 healthy volunteers using a computerized neuropsychological task, and to determine wheter these choices are the result of goal-directed behavior. The study also aims to assess the modulation of behavioral adaptation by the level of impulsivity, lonilness, empathy, and by the capcity to understand others' intenstions.

NCT ID: NCT04854785 Active, not recruiting - Covid19 Clinical Trials

Neuroinflammation in COVID-19 and Depression

Start date: June 14, 2021
Phase:
Study type: Observational

The purpose of this study is to use state of the art brain imaging technology to investigate neuroinflammation in participants with depression after the respiratory symptoms of coronavirus disease 2019 (COVID-19) have passed.

NCT ID: NCT04832750 Recruiting - Clinical trials for Major Depressive Disorder

Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on Sleep

DREAMS
Start date: May 3, 2021
Phase:
Study type: Observational [Patient Registry]

Advances in repetitive transcranial magnetic stimulation (rTMS) protocols with intermittent theta-burst stimulation (iTBS) have significantly decreased the duration for one single session and thereby enabled accelerated treatment plans with multiple sessions per day, potentially reducing the total treatment duration. This randomized, placebo-controlled study investigates the effects of accelerated iTBS treatment with connectivity-informed neuronavigation on symptom severity, sleep, interoception, and cognitive control in patients with major depressive disorder and with or without comorbid borderline personality disorder using magnetic resonance imaging (MRI).

NCT ID: NCT04740463 Recruiting - Clinical trials for Major Depressive Episode

Assessement of Capacity to Consent

Start date: January 1, 2021
Phase:
Study type: Observational

Any patient can request euthanasia in many of our neighbouring European countries as long as informed consent is given. Psychiatric evaluation is not always mandatory. Faced with the increasing emergence of euthanasia requests in different countries from patients under psychiatric care in France for severe depressive episodes, question arises of a possible alteration in the capacity to give consent in the context of a severe depressive episode. This is a Social and Human Sciences study which does not aim to modify the usual management of patients.

NCT ID: NCT04480918 Recruiting - Clinical trials for Major Depressive Disorder

University of Iowa Interventional Psychiatry Service Patient Registry

Start date: November 2, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of this study is to examine the effects of interventional/procedural therapies for treatment-resistant depression (TRD) and Obsessive-Compulsive Disorder (OCD). These treatments include electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS), racemic ketamine infusion and intranasal esketamine insufflation. The investigators will obtain various indicators, or biomarkers, of a depressed individuals' state before, during, and/or after these treatments. Such biomarkers include neurobehavioral testing, neuroimaging, electroencephalography, cognitive testing, vocal recordings, epi/genetic testing, and autonomic nervous system measures (i.e. "fight-or-flight" response). The results obtained from this study may provide novel antidepressant treatment response biomarkers, with the future goal of targeting a given treatment to an individual patient ("personalized medicine").